Why Side Effects Happen and How They’re Managed
- CAR T-Cell Therapy can trigger an intense immune response, releasing a surge that can cause inflammation throughout the body — this is what leads to side effects like fever, low blood pressure, and confusion.
- These reactions, including Cytokine Release Syndrome (CRS) and neurological effects (ICANS), are well-understood and occur because the immune system is powerfully activated to attack cancer.
- The good news: these side effects are typically highly manageable with prompt treatment — doctors use medications like tocilizumab and steroids, along with supportive care, to help patients recover safely.
Understanding Side Effects from CAR T- Cell Therapy: What Patients Should Know
CAR T-Cell Therapy, commonly called CAR T-Cell Therapy, is one of the most exciting advances in modern cancer treatment. However, CAR T-Cell Therapy can also cause unique and sometimes serious side effects. Understanding what to expect, how these side effects are managed, and what they mean for your long-term outcome can help you feel more informed and prepared during treatment.“There are several toxicities or at least risks associated with CAR T-Cells that are unique to the CAR T-Cell treatment,” says Dr. Jonathon Cohen, a professor of hematology and medical oncology at Emory University School of Medicine and the Winship Cancer Institute. “Fortunately, we now have a number of methods to treat [them].”
Read MoreThe Most Common Side Effects of CAR T-Cell Therapy
Most people receiving CAR T-Cell Therapy experience some side effects. These typically occur within days to weeks after the infusion, when the engineered T cells start multiplying and attacking cancer cells. The most common side effects include: 1. Cytokine Release Syndrome (CRS)CRS is the most frequent side effect of CAR T-Cell Therapy. It happens when activated T-cells release large amounts of chemical messengers called cytokines into the bloodstream. These cytokines help coordinate the immune response, but in high levels, they can trigger inflammation throughout the body. This is a similar mechanism to an infection, which also triggers the activation of cytokines; hence, CRS mimics the symptoms of an infection.
Symptoms of CRS can range from mild to severe and may include:
- Fever and chills
- Low blood pressure
- Rapid heartbeat
- Shortness of breath
- Fatigue
- Nausea or vomiting
- Muscle or joint pain
CRS usually develops within a few days after the CAR T-Cell infusion but can occur up to two weeks later.
2. Neurological Side Effects (ICANS)
Another common reaction is immune effector cell-associated neurotoxicity syndrome (ICANS). This happens when cytokines or activated immune cells affect the brain and nervous system.
Symptoms may include:
- Confusion or trouble thinking clearly
- Difficulty speaking or writing
- Headache
- Tremors or muscle twitching
- Drowsiness or trouble staying awake
- In rare cases, seizures or swelling in the brain
Most neurological side effects are temporary and improve with treatment, but close monitoring is important.
3. Low Blood Cell Counts (Cytopenias)
CAR T-Cell Therapy can temporarily lower your blood cell counts, including white blood cells (which fight infection), red blood cells (which carry oxygen), and platelets (which help with clotting). This can make you more prone to infections, fatigue, or bruising.
Low blood counts often begin a few days after treatment and may last for several weeks. Your care team will monitor your blood counts closely and may give you growth factors, transfusions, or antibiotics to help your body recover.
4. Infections
Because both chemotherapy and CAR T-Cell Therapy can weaken the immune system, you may be at increased risk for infections—especially during the first few months. Doctors may prescribe preventive antibiotics or antivirals, and you may need to avoid large crowds or sick contacts during recovery.
5. Fatigue and Weakness
Many people experience significant fatigue after CAR T-Cell Therapy. This may result from the immune reaction itself, low blood counts, medications, or the physical stress of treatment. Most patients gradually regain strength over time, but rest, good nutrition, and gentle activity can help.
How Are These Side Effects Treated?
CAR T-Cell Therapy is always administered at specialized centers with experienced medical teams. Patients are monitored very closely, often staying in the hospital for at least a week after infusion, and followed closely in the clinic for several weeks afterward.
Treatment Approaches Include:
- Supportive care: Oxygen, IV fluids, medications to control fever or blood pressure, and close monitoring in a hospital setting.
- Tocilizumab (Actemra): This drug blocks a specific cytokine (IL-6) that drives inflammation in CRS. It can quickly reduce fever and stabilize blood pressure.
- Corticosteroids (like dexamethasone): Used if symptoms are more severe or don’t respond to tocilizumab. Steroids can reduce inflammation and also help with neurological symptoms.
- Anti-seizure medicines: If you develop neurologic symptoms or are at high risk for seizures, your doctor may prescribe medications like levetiracetam as a preventive measure.
- Blood and platelet transfusions: To treat anemia or prevent bleeding if counts drop too low.
- Antibiotics or antivirals: To treat or prevent infections.
Because these treatments are well-established, most patients can be safely supported through side effects and make a full recovery. Dr. Jonathon Cohen, a medical oncologist at the Emory Winship Cancer Institute, assures that although “These are all things that can happen that can honestly sometimes lead a patient to have to spend time in the intensive care unit. Fortunately, we have excellent therapies to manage this, and this is almost entirely reversible, but it does require awareness.”
What Exactly Is Cytokine Release Syndrome (CRS)?
As mentioned earlier, CRS is an immune overreaction caused by the release of high levels of cytokines—substances that help immune cells communicate and coordinate their attack on cancer. While this is part of how CAR T-Cells work, the resulting “cytokine storm” can sometimes overwhelm the body.
Doctors grade CRS on a scale from 1 (mild) to 4 (life-threatening) based on symptoms like fever, blood pressure, and oxygen levels.
- Mild CRS (Grade 1–2): You might have a fever, fatigue, or mild low blood pressure. Usually treated with fluids, fever reducers, and close monitoring.
- Severe CRS (Grade 3–4): May involve dangerously low blood pressure, high fever, or low oxygen levels. This may require intensive care, IV medications to support blood pressure, and immune-modulating drugs like tocilizumab and steroids.
CRS is not an allergic reaction or infection—it’s an immune system overdrive. The good news is that CRS is well understood, and treatments are highly effective at reversing it once recognized early.
How Is CRS Treated?
If CRS develops, your healthcare team will act quickly. Treatment is tailored to the severity:
- Mild CRS: Supportive care (fluids, fever management) and close observation. Most mild cases resolve on their own.
- Moderate CRS: Tocilizumab is usually given to block IL-6 and reduce inflammation. Symptoms often improve within hours.
- Severe CRS: In addition to tocilizumab, corticosteroids are added to further calm the immune system. You may need oxygen or medications to support your heart and blood pressure.
- Intensive care: In rare cases, patients may be treated in the ICU for close monitoring and advanced support, but most recover fully with proper care.
Do These Treatments Affect My Chances of Cure?
This is an important and common question. Understandably, patients worry that medications used to control side effects—especially steroids or tocilizumab—might reduce the power of CAR T-Cells or make the therapy less effective.
The reassuring answer from current research is: No, these treatments do not appear to reduce your chances of cure.
Studies have shown that when CRS or neurological side effects are treated promptly and appropriately, CAR T-Cells continue to work effectively against cancer. In fact, managing these side effects quickly can help ensure your body can safely tolerate the treatment and allow the CAR T-Cells to keep fighting.
In some cases, patients who experience side effects such as CRS actually demonstrate that the CAR T-Cells are highly active—though not everyone who benefits will develop these reactions.
Learn more about SurvivorNet's rigorous medical review process.
